eBioMedicine in conversation with

eBioMedicine in conversation with

By The Lancet GroupMedicineHealth & Fitness
Download on the App Store

eBioMedicine in conversation with episodes

  • Marc Mansour and Victor Llombart on MYC in cancer

    Professor Marc Mansour and Dr Victor Llombart join eBioMedicine to discuss the “undruggable” MYC in cancer. 

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    15 min
  • Rachel Deer on long COVID

    Rachel Deer joins eBioMedicine to present a study encouraging characterization of long COVID symptoms via human phenotype ontology.


    Read the full article:
    Characterizing Long COVID: Deep Phenotype of a Complex Condition

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    17 min
  • James Zou & David Ouyang on deep learning and hidden clinical correlates

    James Zou & David Ouyang join eBioMedicine to discuss issues around deep learning and hidden clinical correlates.

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    15 min
  • Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs

    Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and eBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.


    Read the full Series:
    https://www.thelancet.com/series/big-data-childhood-infections-LMICs 

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    23 min
  • Anthony Chirwa and Ben Morton on the importance of localised research

    Dr Anthony Chirwa and Dr Ben Morton join eBioMedicine to discuss controlled infections in Streptococcus Pneumoniae and the importance of localised research.


    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00372-8/fulltext

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    18 min
  • Jodi Sherman on the intersection between healthcare and climate change

    Jodi Sherman joins Julie Stacey and Liam Messin of eBioMedicine to discuss the intersection between healthcare and climate change.

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    17 min
  • Grace Fox and Dr Manoj Lalu on the importance of patient engagement in preclinical research

    How can we ensure that research being conducted is relevant to its ultimate end-users? Grace Fox and Dr Manoj Lalu join eBioMedicine to discuss the importance of patient engagement in preclinical research.


    Further reading:
    Patient engagement in preclinical laboratory research: A scoping review

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    14 min
  • Aleix Prat on chemotherapy and menopause

    Dr Aleix Prat on the relationship between chemotherapy effectiveness and menopause in patients with breast cancer.


    Further reading:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00244-9/fulltext

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    10 min
  • Viviana Simon and Maria Rescigno on mRNA vaccine dosing after prior infection

    Dr. Viviana Simon and Dr. Maria Rescigno discuss their proposal that people who have recovered from symptomatic COVID-19 may require only one dose of an mRNA vaccine.


    Further reading:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00194-8/fulltext

    Continue this conversation on social!

    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    15 min

About eBioMedicine in conversation with

From the publisher's feed

Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to this…

More shows like eBioMedicine in conversation with

The Lancet Voice by The Lancet Group

The Lancet Voice

22 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health Western Pacific in conversation with by The Lancet Group

The Lancet Regional Health Western Pacific in conversation with

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners